CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 59 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $152,000 | +47.6% | 38,010 | 0.0% | 0.88% | +99.3% |
| Q2 2020 | $103,000 | +28.8% | 38,010 | 0.0% | 0.44% | -52.9% |
| Q1 2020 | $80,000 | -61.4% | 38,010 | 0.0% | 0.94% | +81.9% |
| Q4 2019 | $207,000 | +81.6% | 38,010 | 0.0% | 0.51% | +102.4% |
| Q3 2019 | $114,000 | -89.3% | 38,010 | -86.7% | 0.25% | -75.6% |
| Q2 2019 | $1,065,000 | -7.0% | 284,869 | 0.0% | 1.04% | +11.9% |
| Q1 2019 | $1,145,000 | +9.6% | 284,869 | 0.0% | 0.93% | -21.9% |
| Q4 2018 | $1,045,000 | – | 284,869 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,101,709 | $7,475,000 | 1.50% |
| ADAMS STREET PARTNERS LLC | 3,275,616 | $7,894,000 | 1.20% |
| Telemetry Investments, L.L.C. | 192,909 | $465,000 | 0.60% |
| CHI Advisors LLC | 400,000 | $964,000 | 0.32% |
| Orbimed Advisors | 6,943,654 | $16,734,000 | 0.22% |
| Ikarian Capital, LLC | 482,610 | $1,163,000 | 0.17% |
| Anson Funds Management LP | 528,358 | $1,273,000 | 0.12% |
| BVF INC/IL | 1,370,947 | $3,304,000 | 0.12% |
| VR Adviser, LLC | 250,000 | $603,000 | 0.08% |
| PURA VIDA INVESTMENTS, LLC | 492,384 | $1,187,000 | 0.04% |